Stage Iiia Non-small Cell Lung Cancer

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer [Phase 3]

  Phase 3 clinical trial update describing a study comparing treatment given before versus after surgery in patients with resectable stage II …

• CLINICAL_TRIALS trial_result · 2025-11-12
  Clinical Trial Update: Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer [Phase 2]

  Phase 2 trial evaluating MRI-guided adaptive radiation therapy with concurrent chemotherapy and consolidation durvalumab in inoperable Stage…

• CLINICAL_TRIALS trial_result · 2025-06-12
  Clinical Trial Update: Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery [Phase 2]

  This Phase 2 clinical trial update reports results for a hypofractionated boost before chemoradiation in patients with stage II–III non-smal…

• CLINICAL_TRIALS research · 2025-04-09
  Clinical Trial Update: Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) [Phase 2]

  This document reports a Phase 2 clinical trial update examining atezolizumab in combination with induction chemotherapy and radiotherapy for…

• CLINICAL_TRIALS trial_result · 2024-03-04
  Clinical Trial Update: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [Phase 2]

  Phase 2 clinical trial of FR901228 in patients with refractory or progressive small cell lung cancer or non-small cell lung cancer has compl…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-12-06
  Clinical Trial Update: Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma [Phase 1]

  Phase 1 trial assessing trigriluzole in combination with nivolumab and pembrolizumab for various metastatic or unresectable solid tumors and…

• CLINICAL_TRIALS trial_result · 2021-05-17
  Clinical Trial Update: Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery [Phase 1, Phase 2]

  A phase 1/2 trial evaluating proton beam radiation therapy with chemotherapy for Stage IIIA non-small cell lung cancer that is resectable, c…

• CLINICAL_TRIALS trial_result · 2020-06-23
  Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]

  A Phase 2 trial assessing whether adding metformin hydrochloride to chemotherapy and radiation improves outcomes for Stage III non-small cel…

• CLINICAL_TRIALS trial_result · 2019-01-03
  Clinical Trial Update: 18F-FSPG PET/CT for Cancer Patients on Therapy [Phase 2]

  Phase 2 clinical trial update on 18F-FSPG PET/CT for cancer patients undergoing therapy; study status completed with results posted.

• CLINICAL_TRIALS trial_result · 2018-07-02
  Clinical Trial Update: Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery [NA]

  The Wake Forest University Health Sciences trial NCT02566421, evaluating genomic sequencing to guide treatment for metastatic, recurrent, or…

• CLINICAL_TRIALS trial_result · 2016-02-29
  Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 2]

  Phase 2 trial results evaluating the combination of chemotherapy, radiation therapy, and bevacizumab in newly diagnosed, unresectable stage …

• CLINICAL_TRIALS trial_result · 2013-02-27
  Clinical Trial Update: Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]

  A Phase 3 trial evaluating whether adding Gefitinib to combination chemotherapy and radiation therapy improves outcomes for unresectable sta…

• CLINICAL_TRIALS trial_result · 2013-02-01
  Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]

  Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminate…

• CLINICAL_TRIALS withdrawal · 2012-06-29
  Clinical Trial Update: Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation [NA]

  The clinical trial evaluating FDG-PET/CT scans to predict response in stage IIIA non-small cell lung cancer during chemoradiation has been w…